ELVERDİ, T. Et Al. 2013. Elevated Thymidine Kinase Levels (TKI)may identify patients at high risk of disease progression in newly diagnosed multiple myeloma.. 4 th International Congress on Leukemia Lymphoma Myeloma , (İstanbul, Turkey), 310-311.

ELVERDİ, T., TEMURHAN, S., OSMANBAŞOĞLU, E., AKGÜL, S., AYDIN, F., NALÇACI, M., ... BEŞIŞIK, S.(2013). Elevated Thymidine Kinase Levels (TKI)may identify patients at high risk of disease progression in newly diagnosed multiple myeloma. . 4 th International Congress on Leukemia Lymphoma Myeloma (pp.310-311). İstanbul, Turkey

ELVERDİ, Tuğrul Et Al. "Elevated Thymidine Kinase Levels (TKI)may identify patients at high risk of disease progression in newly diagnosed multiple myeloma.," 4 th International Congress on Leukemia Lymphoma Myeloma, İstanbul, Turkey, 2013

ELVERDİ, Tuğrul Et Al. "Elevated Thymidine Kinase Levels (TKI)may identify patients at high risk of disease progression in newly diagnosed multiple myeloma.." 4 th International Congress on Leukemia Lymphoma Myeloma , İstanbul, Turkey, pp.310-311, 2013

ELVERDİ, T. Et Al. (2013) . "Elevated Thymidine Kinase Levels (TKI)may identify patients at high risk of disease progression in newly diagnosed multiple myeloma.." 4 th International Congress on Leukemia Lymphoma Myeloma , İstanbul, Turkey, pp.310-311.

@conferencepaper{conferencepaper, author={Tuğrul ELVERDİ Et Al. }, title={Elevated Thymidine Kinase Levels (TKI)may identify patients at high risk of disease progression in newly diagnosed multiple myeloma.}, congress name={4 th International Congress on Leukemia Lymphoma Myeloma}, city={İstanbul}, country={Turkey}, year={2013}, pages={310-311} }